An update of the phase II window study of the farnesyl transferase inhibitor (FTI), R115777, followed by a phase III trial of 13-cis retinoic, cytosine arabinoside, fludarabine and stem cell transplantation (SCT) in children with juvenile myelomonocytic leukemia (JMML). A children's oncology group study
Titel:
An update of the phase II window study of the farnesyl transferase inhibitor (FTI), R115777, followed by a phase III trial of 13-cis retinoic, cytosine arabinoside, fludarabine and stem cell transplantation (SCT) in children with juvenile myelomonocytic leukemia (JMML). A children's oncology group study
Auteur:
Castleberry, R. Loh, M. Jayaprakash, N. Peterson, A. Casey, V. Chang, M. Widemann, B. Emanuel, P.